Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103773822B reveals streamlined Simvastatin production reducing steps and solvents for supply chain efficiency.
Patent CN112795606A reveals a novel PNP/NRK enzymatic route for NMN. Achieve superior conversion rates and cost efficiency in pharmaceutical intermediate manufacturing.
Patent CN114592027A reveals a novel two-step method for Tauroursodeoxycholic Acid production, offering significant cost reduction in API manufacturing and high-purity outcomes.
Patent CN105392891B enables high-yield production of optically active D/L amino acids with thiol groups. Enhances supply chain reliability and reduces manufacturing costs for peptide synthesis.
Novel enzyme mutant technology enables green cordycepin production. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN110551771B details a green enzymatic route for chiral 3-amino-1-butanol. Discover cost-effective, high-purity pharmaceutical intermediate manufacturing solutions.
Patent CN109053526A details efficient synthesis. Enhances supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing for global buyers.
Patent CN110643670A details a high-yield chemoenzymatic route for D-glutamine production, offering significant cost reduction in pharmaceutical manufacturing and scalable supply solutions.
Patent CN115873813A reveals cascade enzymatic route for Boldenone. Offers high yield, mild conditions, and scalable manufacturing for pharmaceutical supply chains.
Novel L-threonine aldolase enables green synthesis of antibiotic intermediates with high stereoselectivity and reduced environmental impact.
Patent CN111233949A details a novel one-pot three-enzyme method for GM3 synthesis, offering high stereoselectivity and cost reduction for pharmaceutical intermediate manufacturing.
Patent CN102899367B details a hybrid bio-chemical synthesis for high-purity Tenofovir. This method offers significant cost reduction and scalable manufacturing for API intermediates.
Patent CN109306366B reveals a novel enzymatic route for PT141, offering higher purity and yield. Discover cost-effective manufacturing solutions for this peptide API intermediate.
Patent CN106701882A details a novel chemo-enzymatic route for UDCA production offering high purity and scalable manufacturing capabilities for global pharmaceutical supply chains.
Patent CN106957878B reveals a novel enzymatic route for 2-phenethyl alcohol using L-phenylalanine. Achieves high conversion without toxic byproducts, offering a reliable supply chain solution.
Novel chemical-enzymatic route for Mirogabalin ensures high purity and yield. Ideal for reliable API supply chain partners seeking cost-effective manufacturing solutions.
Patent CN111194304A details an enzymatic method for high-purity bridged ring intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Discover advanced processes for preparing cyclopenta[d]pyrimidin-4-yl piperazine compounds. Enhance supply chain reliability and reduce manufacturing costs for AKT inhibitors.
Novel 4-step enzymatic route for Ritlecitinib Tosylate. Eliminates metal catalysts and chiral columns. High purity, scalable supply for global pharma partners.
Overcome low yields and chiral challenges in ezetimibe production. Discover enzymatic synthesis trends for high optical purity intermediates. Find reliable suppliers for API manufacturing.